Literature DB >> 32723484

Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes.

Tatjana Nikolic1, Jaap J Zwaginga2, Bas S Uitbeijerse3, Nicky J Woittiez2, Eelco J de Koning3, Henk-Jan Aanstoot4, Bart O Roep5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32723484     DOI： 10.1016/S2213-8587(20)30104-2

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  13 in total

Review 1.  100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

Authors:  Anette-Gabriele Ziegler; Thomas Danne; Carolin Daniel; Ezio Bonifacio
Journal:  Med (N Y)       Date:  2021-09-15

2.  Immunodominant MHC-II (Major Histocompatibility Complex II) Restricted Epitopes in Human Apolipoprotein B.

Authors:  Payel Roy; John Sidney; Cecilia S Lindestam Arlehamn; Elizabeth Phillips; Simon Mallal; Sujit Silas Armstrong Suthahar; Monica Billitti; Paul Rubiro; Daniel Marrama; Fabrizio Drago; Jenifer Vallejo; Vasantika Suryawanshi; Marco Orecchioni; Jeffrey Makings; Paul J Kim; Coleen A McNamara; Bjoern Peters; Alessandro Sette; Klaus Ley
Journal:  Circ Res       Date:  2022-06-29       Impact factor: 23.213

Review 3.  Dendritic Cells and Their Immunotherapeutic Potential for Treating Type 1 Diabetes.

Authors:  Farhan Ullah Khan; Puregmaa Khongorzul; Ahmed Aziz Raki; Ashwini Rajasekaran; Denis Gris; Abdelaziz Amrani
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

Review 4.  Islet-Resident Dendritic Cells and Macrophages in Type 1 Diabetes: In Search of Bigfoot's Print.

Authors:  Henner Zirpel; Bart O Roep
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-12       Impact factor: 5.555

Review 5.  Novel delivery mechanisms for antigen-specific immunotherapy.

Authors:  Tobias Neef; Stephen D Miller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2021-08-01       Impact factor: 3.626

6.  Preclinical evaluation of a precision medicine approach to DNA vaccination in type 1 diabetes.

Authors:  Jorge Postigo-Fernandez; Rebuma Firdessa-Fite; Rémi J Creusot
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-06       Impact factor: 12.779

Review 7.  Type 1 diabetes mellitus as a disease of the β-cell (do not blame the immune system?).

Authors:  Bart O Roep; Sofia Thomaidou; René van Tienhoven; Arnaud Zaldumbide
Journal:  Nat Rev Endocrinol       Date:  2020-12-08       Impact factor: 43.330

Review 8.  Therapeutic Strategies for Diabetes: Immune Modulation in Pancreatic β Cells.

Authors:  Sugyeong Jo; Sungsoon Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-17       Impact factor: 5.555

9.  Human islet T cells are highly reactive to preproinsulin in type 1 diabetes.

Authors:  Amanda M Anderson; Laurie G Landry; Aimon A Alkanani; Laura Pyle; Alvin C Powers; Mark A Atkinson; Clayton E Mathews; Bart O Roep; Aaron W Michels; Maki Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2021-10-12       Impact factor: 12.779

10.  1,25-dihydroxyvitamin D3 induces stable and reproducible therapeutic tolerogenic dendritic cells with specific epigenetic modifications.

Authors:  Kayleigh M van Megen; Zhuo Chen; Antoinette M Joosten; Sandra Laban; Jaap-Jan Zwaginga; Rama Natarajan; Tatjana Nikolic; Bart O Roep
Journal:  Cytotherapy       Date:  2021-01-15       Impact factor: 5.414
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.